Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 5,061,380 $ 6,975,302
Accounts receivable 5,019 5,137
Marketable securities-current 2,997,999 2,996,960
Inventories 3,213,182 1,799,769
Deferred offering costs 221,894 105,500
Due from affiliated companies 286,922 286,922
Prepaid expenses and other current assets 819,868 903,756
Total Current Assets 12,606,264 13,073,346
Marketable securities - non current 2,980,044 3,067,137
Property and equipment, net 3,433,042 2,883,171
Operating lease right of use asset 1,457,424 1,550,530
Security deposit 25,000 25,000
Total Assets 20,501,774 20,599,184
Current Liabilities:    
Accounts payable 1,969,493 1,200,861
Accrued liabilities 660,038 456,814
Contract liability 200 14,100
Due to affiliated companies 115,043 115,043
Operating lease right of use liability 377,856 368,602
Total Current Liabilities 3,122,630 2,155,420
Economic Injury Disaster Loan 499,900 499,900
Operating lease liability - noncurrent 1,146,029 1,244,164
Total Liabilities 4,768,559 3,899,484
Stockholders’ equity:    
Preferred stock: 10,000,000 authorized; $0.001 par value; no shares issued and outstanding
Common stock: 50,000,000 authorized; $0.001 par value; 7,000,000 and 7,000,000 shares issued and outstanding, respectively 7,000 7,000
Additional paid-in capital 18,935,088 18,710,256
Accumulated deficit (3,208,873) (2,017,556)
Total stockholders’ equity 15,733,215 16,699,700
Total Liabilities and Stockholders’ Equity $ 20,501,774 $ 20,599,184